Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 77.78B | 79.09B | 78.61B | 82.92B | 75.95B | 73.62B |
Gross Profit | 13.87B | 14.19B | 14.18B | 14.85B | 15.66B | 16.00B |
EBITDA | 2.60B | 3.81B | 2.47B | 2.13B | 5.42B | 7.29B |
Net Income | 2.06B | 427.00M | -8.21B | -1.20B | 1.52B | 3.21B |
Balance Sheet | ||||||
Total Assets | 84.17B | 79.50B | 82.66B | 86.22B | 80.12B | 76.86B |
Cash, Cash Equivalents and Short-Term Investments | 7.15B | 7.72B | 6.85B | 6.89B | 7.59B | 8.13B |
Total Debt | 14.65B | 14.65B | 14.65B | 11.10B | 5.20B | 5.20B |
Total Liabilities | 43.36B | 40.17B | 43.11B | 40.02B | 32.40B | 30.48B |
Stockholders Equity | 40.81B | 39.34B | 39.55B | 46.20B | 47.73B | 46.38B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.11B | -2.37B | -5.91B | -1.41B | -733.00M |
Operating Cash Flow | 0.00 | 2.69B | 1.88B | -1.07B | 4.71B | 4.51B |
Investing Cash Flow | 0.00 | -1.92B | -3.79B | -4.48B | -5.03B | -2.83B |
Financing Cash Flow | 0.00 | -1.25B | 1.76B | 4.55B | -860.00M | -650.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥55.68B | 8.05 | 4.15% | 1.91% | 21.48% | ||
78 Outperform | ¥183.43B | 12.05 | 4.87% | 0.50% | -8.77% | ||
78 Outperform | ¥19.92B | 7.33 | 4.75% | 8.23% | 37.45% | ||
76 Outperform | ¥19.35B | 17.15 | 4.05% | 8.38% | -43.33% | ||
62 Neutral | $10.36B | 10.18 | 0.09% | 2.81% | 2.25% | -33.44% | |
49 Neutral | ¥32.45B | 94.32 | 4.54% | 0.37% | -364.90% | ||
45 Neutral | ¥15.78B | 35.78 | 1.83% | 0.62% | ― |
Achilles Corporation announced a correction to its financial materials for the fiscal year ended March 31, 2025. The correction involved an error in the financial results forecast for the fiscal year ending March 31, 2026, specifically adjusting the annual dividends from 40 Yen to 20 Yen. This correction may impact shareholder expectations and the company’s financial outlook.
Achilles Corporation reported significant extraordinary losses and income for the fiscal year ending March 31, 2025, primarily due to impairments in its Chinese subsidiary and gains from retirement benefit trust adjustments. The company’s financial results showed variances from forecasts, with a decline in net sales attributed to struggles in the automotive materials business and a weak domestic housing market. Despite cost reduction efforts that improved domestic profitability, overseas challenges led to lower-than-expected profits, impacting stakeholders and highlighting the need for strategic adjustments.
Achilles Corporation has announced its Mid-term Management Plan for FY2025–FY2027, aiming for net sales of 88.0 billion yen and operating profits of 3.0 billion yen by 2027. The plan emphasizes reforming the business portfolio, enhancing productivity, and improving technological capabilities to support growth amidst geopolitical uncertainties. The company is committed to increasing corporate value and achieving consistent growth through strategic resource allocation and innovation.
Achilles Corporation reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a slight increase in net sales by 0.6% to ¥79,093 million. Despite this, the company experienced an operating loss of ¥436 million and an ordinary loss of ¥220 million, although it achieved a profit attributable to owners of the parent of ¥427 million, marking a significant recovery from the previous year’s loss. The company’s financial position remains stable with a slight improvement in equity ratio to 49.5%. The forecast for the fiscal year ending March 31, 2026, anticipates further growth in net sales and profits, indicating a positive outlook for the company’s financial health.